References
Freeman BD, Danner RL, Banks SM, Natanson C (2001) Safeguarding patients in clinical trials with high mortality rates. Am J Respir Crit Care Med 164:190–192
Davidoff F, DeAngelis CD, Drazen JM, Nicholls MG, Hoey J, Hojgaard L, Horton R, Kotzin S, Nylenna M, Overbeke JP, Sox HC, Van der Weyden MB, Wilkes MS (2001) Sponsorship, authorship and accountability. N Engl J Med 345:825–826
US FDA (1996) Protection of human subjects: informed consent and waiver of informed consent requirements in certain emergency research final rules. Federal register 5:497–515
Lemaire F, Blanch L, Cohen S, Sprung C and the working group in ethics (1997) Informed consent for research purposes: an official statement of the ESICM. Intensive Care Med 23:338–341
Directive 2001/20/EC of the European Parliament and of the Council of 4 April 2001 on the approximation of the laws, regulations and administrative provisions of the Member States relating to the implementation of good clinical practice in the conduct of clinical trials on medicinal products for human use. O.J. L 121/34
Visser HKA (2001) Non therapeutic research in the EU in adults incapable of giving consent? Lancet 357:818–819
World Medical Association (2000) Declaration of Helsinki: ethical principles for medical research involving human subjects (5th revision). Edinburgh, Scotland
Appelbaum PS, Roth LH, Lidz CW, Benson P, Winslade W (1987) False hopes and best data: consent to research and therapeutic misconception. Hastings Cent Rep 17:20–24
Freedman B (1987) Equipoise and the ethics of clinical research. N Engl J Med 317:141–145
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lemaire, F. European Society of Intensive Care Medicine statement. Intensive Care Med 28, 1218–1219 (2002). https://doi.org/10.1007/s00134-002-1417-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00134-002-1417-0